Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests.
Early diagnostic solutions
BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.
Supplier: Winhealth medical is an enterprise in the life and health, is a national innovation oriented enterprises, is the national health protection products designated supply production units, is china's leading integrated medical health industry company, has set research and development of science and technology, health, engineering, logistics distribution, international management as one of the major health industry chain.
winhealth medical science and technology research and development with the biotechnology center, research center of traditional chinese medicine.